JW (CAYMAN) THERAPEUTICS CO. LTD revenue breakdown overview

JW (CAYMAN) THERAPEUTICS CO. LTD revenue for the last year amounted to 191.26 M HKD, the most of which — 192.11 M HKD — came from its highest performing source at the moment, Anti-tumor Drugs, the year earlier bringing 169.43 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought JW (CAYMAN) THERAPEUTICS CO. LTD 192.11 M HKD, and the year before that — 169.43 M HKD.